Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 8/20 | 0.59 |
| ▸ | METAP2 | P50579 | 5/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | NPC1 | O15118 | 2/20 | 0.59 |
| ▸ | RAB9A | P51151 | 2/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | FKBP1A | P62942 | 1/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | HPGD | P15428 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Thiophanate SCHEMBL7196579 | 0.91 | METAP1 (0.55) | METAP1METAP2SMN1; SMN2KDM4ENPC1 | |
| Carbendazim SCHEMBL18131962 | 0.83 | METAP1 (0.65) | METAP1METAP2SMN1; SMN2KDM4ENPC1 | |
| Thiophanate Methyl SCHEMBL28140120 | 0.80 | METAP1 (0.58) | METAP1METAP2SMN1; SMN2KDM4ENPC1 | |
| Thiabendazole SCHEMBL675655 | 0.77 | METAP1 (0.83) | METAP1METAP2SMN1; SMN2KDM4ENPC1 | |
| Thiabendazole SCHEMBL30099775 | 0.77 | METAP1 (0.83) | METAP1METAP2SMN1; SMN2KDM4ENPC1 | |
| Thiabendazole SCHEMBL625588 | 0.77 | METAP1 (1.00) | METAP1METAP2SMN1; SMN2KDM4ENPC1 | |
| Thiabendazole SCHEMBL19842 | 0.77 | METAP1 (1.00) | METAP1METAP2SMN1; SMN2KDM4ENPC1 | |
| Thiabendazole SCHEMBL29370729 | 0.77 | METAP1 (1.00) | METAP1METAP2SMN1; SMN2KDM4ENPC1 | |
| Thiabendazole SCHEMBL28860081 | 0.76 | METAP1 (0.81) | METAP1METAP2SMN1; SMN2KDM4ENPC1 | |
| Thiabendazole SCHEMBL28170923 | 0.76 | METAP1 (0.71) | METAP1METAP2SMN1; SMN2KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 209 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090117200-A1 | Fungicide Composition Comprising a Phosphorous Acid Derivative, a Mandelamide Type Compound and a Further Fungicide Compound | BAYER SAS (FR) | 2009-05-07 | — | — | US | claimed |
| EP-1931200-A1 | FUNGICIDE COMPOSITION COMPRISING AN ARYLAMIDINE DERIVATIVE AND TWO KNOWN FUNGICIDE COMPOUNDS | Bayer CropScience AG (DE) | 2008-06-18 | — | — | EP | claimed |
| EP-1898709-A1 | FUNGICIDE COMPOSITION COMPRISING A PHOSPHOROUS ACID DERIVATIVE, A MANDELAMIDE TYPE COMPOUND AND A FURTHER FUNGICIDE COMPOUND | Bayer CropScience S.A. (FR) | 2008-03-19 | — | — | EP | claimed |
| WO-2007031507-A1 | FUNGICIDE COMPOSITION COMPRISING AN ARYLAMIDINE DERIVATIVE AND TWO KNOWN FUNGICIDE COMPOUNDS | BAYER CROPSCIENCE AG (DE) | 2007-03-22 | — | — | WO | claimed |
| WO-2006136551-A1 | FUNGICIDE COMPOSITION COMPRISING A PHOSPHOROUS ACID DERIVATIVE, A MANDELAMIDE TYPE COMPOUND AND A FURTHER FUNGICIDE COMPOUND | BAYER CROPSCIENCE SA (FR) | 2006-12-28 | — | — | WO | claimed |
| US-20240199709-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | SPOGEN BIOTECH INC (US) | 2024-06-20 | — | — | US | disclosed |
| US-11905315-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2024-02-20 | — | — | US | disclosed |
| US-20210179672-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | GENISYS CREDIT UNION | 2021-06-17 | — | — | US | disclosed |
| US-10836800-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2020-11-17 | — | — | US | disclosed |
| US-20200190149-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | GENISYS CREDIT UNION | 2020-06-18 | — | — | US | disclosed |
| US-10407472-B2 | Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria | SPOGEN BIOTECH INC. (US) | 2019-09-10 | — | — | US | disclosed |
| US-20180099999-A1 | FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA | GENISYS CREDIT UNION | 2018-04-12 | — | — | US | disclosed |
| WO-2006108792-A1 | NEW HETEROCYCLYLETHYLBENZAMIDE DERIVATIVES | BAYER CROPSCIENCE SA (FR) | 2006-10-19 | — | — | WO | disclosed |
| WO-2006050772-A1 | VINYLAMINOPYRAZOLE DERIVATIVES AS PESTICIDES | MERIAL LTD. (US) | 2006-05-18 | — | — | WO | disclosed |
| WO-2006008159-A1 | A USE OF SULFONANILIDES AS AGRICULTURAL AND HORTICULTURAL FUNGICIDE | BAYER CROPSCIENCE AG (DE) | 2006-01-26 | — | — | WO | disclosed |
| WO-2006000312-A1 | PESTICIDAL N-PHENYLPYRAZOLE DERIVATIVES | MERIAL LTD. (US) | 2006-01-05 | — | — | WO | disclosed |
| WO-2006000313-A1 | N-PHENYLPYRAZOLE DERIVATIVES AS PESTICIDES | MERIAL LTD. (US) | 2006-01-05 | — | — | WO | disclosed |
| WO-2006000311-A1 | 1-ARYLPYRAZOLE DERIVATIVES PESTICIDAL AGENTS | MERIAL LTD. (US) | 2006-01-05 | — | — | WO | disclosed |
| WO-2006000315-A1 | PESTICIDAL AGENTS ON THE BASIS OF 1- ARYL- AMINOPYRROL | MERIAL LTD. (US) | 2006-01-05 | — | — | WO | disclosed |
| WO-2006000314-A1 | N-PHENYLPYRAZOLE DERIVATIVES AS PESTICIDES | MERIAL LTD. (US) | 2006-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090117200-A1 | Fungicide Composition Comprising a Phosphorous Acid Derivative, a Mandelamide Type Compound and a Further Fungicide Compound | PPA1, PPME1, MTAP | METAP1 234/4885METAP2 182/4885SMN1; SMN2 1171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.